| Marksans Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
| Long Term Debt-Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
| Current Ratio | 3.11 | 3.60 | 3.73 | 3.18 | 2.98 |
| Fixed Assets | 2.41 | 2.31 | 2.11 | 2.28 | 2.29 |
| Inventory | 5.93 | 5.30 | 5.58 | 6.67 | 7.13 |
| Debtors | 2.55 | 2.53 | 2.37 | 3.17 | 3.62 |
| Interest Cover Ratio | 208.91 | 174.63 | 37.58 | 36.40 | 24.24 |
| PBIDTM (%) | 23.32 | 23.67 | 23.26 | 23.69 | 24.16 |
| PBITM (%) | 20.81 | 20.26 | 20.70 | 21.01 | 21.63 |
| PBDTM (%) | 23.22 | 23.56 | 22.71 | 23.12 | 23.27 |
| CPM (%) | 18.54 | 19.09 | 18.26 | 18.48 | 18.94 |
| APATM (%) | 16.03 | 15.68 | 15.70 | 15.80 | 16.41 |
| ROCE (%) | 18.55 | 14.67 | 14.11 | 19.45 | 22.04 |
| RONW (%) | 14.45 | 11.46 | 10.85 | 15.02 | 17.29 |